Agency Information Collection Activities: Submission for OMB Review; Comment Request, 56227-56229 [2020-20089]
Download as PDF
Federal Register / Vol. 85, No. 177 / Friday, September 11, 2020 / Notices
related to finances, environmental
responsibilities, and decision-making
for legal matters.
Proposed Effective Date: 10/16/2020.
Location: https://www2.fmc.gov/
FMC.Agreements.Web/Public/
AgreementHistory/2077.
indirectly acquire FirstBank, both of
Lakewood, Colorado.
Board of Governors of the Federal Reserve
System, September 4, 2020.
Yao-Chin Chao,
Assistant Secretary of the Board.
[FR Doc. 2020–20015 Filed 9–10–20; 8:45 am]
Dated: September 8, 2020.
Rachel Dickon,
Secretary.
BILLING CODE P
[FR Doc. 2020–20066 Filed 9–10–20; 8:45 am]
FEDERAL RESERVE SYSTEM
BILLING CODE 6730–02–P
Change in Bank Control Notices;
Acquisitions of Shares of a Bank or
Bank Holding Company
FEDERAL RESERVE SYSTEM
Formations of, Acquisitions by, and
Mergers of Bank Holding Companies
The companies listed in this notice
have applied to the Board for approval,
pursuant to the Bank Holding Company
Act of 1956 (12 U.S.C. 1841 et seq.)
(BHC Act), Regulation Y (12 CFR part
225), and all other applicable statutes
and regulations to become a bank
holding company and/or to acquire the
assets or the ownership of, control of, or
the power to vote shares of a bank or
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The public portions of the
applications listed below, as well as
other related filings required by the
Board, if any, are available for
immediate inspection at the Federal
Reserve Bank(s) indicated below and at
the offices of the Board of Governors.
This information may also be obtained
on an expedited basis, upon request, by
contacting the appropriate Federal
Reserve Bank and from the Board’s
Freedom of Information Office at
https://www.federalreserve.gov/foia/
request.htm. Interested persons may
express their views in writing on the
standards enumerated in the BHC Act
(12 U.S.C. 1842(c)).
Comments regarding each of these
applications must be received at the
Reserve Bank(s) indicated or the offices
of the Board of Governors, Ann E.
Misback, Secretary of the Board, 20th
Street and Constitution Avenue NW,
Washington DC 20551–0001, not later
than October 13, 2020.
The notificants listed below have
applied under the Change in Bank
Control Act (Act) (12 U.S.C. 1817(j)) and
§ 225.41 of the Board’s Regulation Y (12
CFR 225.41) to acquire shares of a bank
or bank holding company. The factors
that are considered in acting on the
applications are set forth in paragraph 7
of the Act (12 U.S.C. 1817(j)(7)).
The public portions of the
applications listed below, as well as
other related filings required by the
Board, if any, are available for
immediate inspection at the Federal
Reserve Bank(s) indicated below and at
the offices of the Board of Governors.
This information may also be obtained
on an expedited basis, upon request, by
contacting the appropriate Federal
Reserve Bank and from the Board’s
Freedom of Information Office at
https://www.federalreserve.gov/foia/
request.htm. Interested persons may
express their views in writing on the
standards enumerated in paragraph 7 of
the Act.
Comments regarding each of these
applications must be received at the
Reserve Bank indicated or the offices of
the Board of Governors, Ann E.
Misback, Secretary of the Board, 20th
Street and Constitution Avenue NW,
Washington, DC 20551–0001, not later
than September 28, 2020.
A. Federal Reserve Bank of Kansas City
(Dennis Denney, Assistant Vice
President) 1 Memorial Drive, Kansas
City, Missouri 64198–0001:
1. The Reisher Family Foundation,
Lakewood, Colorado; to become a bank
holding company by acquiring 16.95
percent of the voting shares of FirstBank
Holding Company, and thereby
VerDate Sep<11>2014
20:54 Sep 10, 2020
Jkt 250001
PO 00000
Frm 00016
Fmt 4703
Sfmt 4703
56227
A. Federal Reserve Bank of San
Francisco (Sebastian Astrada, Director,
Applications) 101 Market Street, San
Francisco, California 94105–1579:
1. Richard B. Fowler II, Carmichael,
California, and Karl K. Klessig, Sante Fe,
New Mexico; as a group acting in
concert, to acquire additional voting
shares of Golden Pacific Bancorp, Inc.,
and thereby indirectly acquire voting
shares of Golden Pacific Bank, National
Association, both of Sacramento,
California.
Board of Governors of the Federal Reserve
System, September 8, 2020.
Yao-Chin Chao,
Assistant Secretary of the Board.
[FR Doc. 2020–20086 Filed 9–10–20; 8:45 am]
BILLING CODE P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–359/CMS–360,
CMS–10706, CMS–10725 and CMS 10728]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Centers for Medicare &
Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995
(PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, and to allow
a second opportunity for public
comment on the notice. Interested
persons are invited to send comments
regarding the burden estimate or any
other aspect of this collection of
information, including the necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions, the accuracy of
the estimated burden, ways to enhance
the quality, utility, and clarity of the
information to be collected, and the use
of automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
SUMMARY:
E:\FR\FM\11SEN1.SGM
11SEN1
56228
Federal Register / Vol. 85, No. 177 / Friday, September 11, 2020 / Notices
Comments on the collection(s) of
information must be received by the
OMB desk officer by October 13, 2020.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of following:
1. Access CMS’ website address at
website address at https://www.cms.gov/
Regulations-and-Guidance/Legislation/
PaperworkReductionActof1995/PRAListing.html.
2. Call the Reports Clearance Office at
(410) 786–1326.
FOR FURTHER INFORMATION CONTACT:
William Parham at (410) 786–4669.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. The term ‘‘collection of
information’’ is defined in 44 U.S.C.
3502(3) and 5 CFR 1320.3(c) and
includes agency requests or
requirements that members of the public
submit reports, keep records, or provide
information to a third party. Section
3506(c)(2)(A) of the PRA (44 U.S.C.
3506(c)(2)(A)) requires federal agencies
to publish a 30-day notice in the
Federal Register concerning each
proposed collection of information,
including each proposed extension or
reinstatement of an existing collection
of information, before submitting the
collection to OMB for approval. To
comply with this requirement, CMS is
publishing this notice that summarizes
the following proposed collection(s) of
information for public comment:
1. Type of Information Collection
Request: Extension of a currently
approved information collection; Title
of Information Collection:
Comprehensive Outpatient
Rehabilitation Facility (CORF)
Certification and Survey Forms; Use:
The form CMS–359 is an application for
health care providers that seek to
participate in the Medicare program as
a Comprehensive Outpatient
Rehabilitation Facility (CORF). The
form initiates the process for facilities to
become certified as a CORF and it
provides the CMS Location and State
DATES:
VerDate Sep<11>2014
20:54 Sep 10, 2020
Jkt 250001
Survey Agency (SA) staff identifying
information regarding the applicant that
is stored in the Automated Survey
Processing Environment (ASPEN)
system.
The form CMS–360 is a survey tool
used by the SAs to record information
in order to determine a provider’s
compliance with the CORF Conditions
of Participation (COPs) and to report
this information to the Federal
government. The form includes basic
information on the COP requirements,
check boxes to indicate the level of
compliance, and a section for recording
notes. CMS has the responsibility and
authority for certification decisions
which are based on provider
compliance with the COPs and this form
supports this process. Form Number:
CMS–359/360 (OMB control number:
0938–0267); Frequency: Occasionally;
Affected Public: Private Sector (Business
or other for-profits); Number of
Respondents: 49 Number of Responses:
8; Total Annual Hours: 74. (For
questions regarding this collection
contact Caroline Gallaher (410)786–
8705.)
2. Type of Information Collection
Request: New collection (Request for a
new OMB control number); Title of
Information Collection: Generic
Clearance for the Center for Clinical
Standards and Quality IT Product and
Support Teams; Use: The Health
Information Technology for Economic
and Clinical Health (HITECH) Act is
part of the American Reinvestment and
Recovery Act (ARRA) of 2009. As noted
in the HITECH Act, CMS is responsible
for defining ‘‘meaningful use’’ of
certified electronic health record (EHR)
technology and developing incentive
payment programs for Medicare and
Medicaid providers. CMS is continually
implementing and updating information
systems as legislation and requirements
change. To support this initiative, CCSQ
IT Product and Support Teams (CIPST)
must have the capacity for engagement
with users in an ongoing variety of
research, discovery, and validation
activities to create and refine systems
that do not place an undue burden on
users and instead are efficient, usable,
and desirable.
The Center for Clinical Standards and
Quality (CCSQ) is responsible for
administering appropriate information
systems so that the public can submit
healthcare-related information. While
beneficiaries ultimately benefit, the
primary users of (CIPST) are healthcare
facility employees and contractors. They
are responsible for the collection and
submission of appropriate beneficiary
data to CMS to receive merit-based
compensation.
PO 00000
Frm 00017
Fmt 4703
Sfmt 4703
The generic clearance will allow a
rapid response to inform CMS
initiatives using a mixture of qualitative
and quantitative consumer research
strategies (including formative research
studies and methodological tests) to
improve information systems that serve
CMS audiences. CMS implements
human-centered methods and activities
for the improvement of policies,
services, and products. As information
systems and technologies are developed
or improved upon, they can be tested
and evaluated for end-user feedback
regarding utility, usability, and
desirability. The overall goal is to apply
a human-centered engagement model to
maximize the extent to which CMS
CIPST product teams can gather ongoing
feedback from consumers. Feedback
helps engineers and designers arrive at
better solutions, therefore minimizing
the burden on consumers and meeting
their needs and goals.
The activities under this clearance
involve voluntary engagement with
target CIPST users to receive design and
research feedback. Voluntary end-users
from samples of self-selected customers,
as well as convenience samples, with
respondents selected either to cover a
broad range of customers or to include
specific characteristics related to certain
products or services. All collection of
information under this clearance is for
use in both quantitative and qualitative
groups collecting data related to humancomputer interactions with information
system development. We will use the
findings to create the highest possible
public benefit. Form Number: CMS–
10706 (OMB control number: 0938–
NEW); Frequency: Occasionally;
Affected Public: Individuals and Private
Sector (Business or other for-profit and
Not-for-profit institutions); Number of
Respondents: 11,476; Total Annual
Responses: 11,476; Total Annual Hours:
4,957. (For policy questions regarding
this collection contact Stephanie Ray at
410–786–0971).
3. Type of Information Collection
Request: New information collection;
Title of Information Collection:
Pharmacy Benefit Manager
Transparency; Use: The Patient
Protection and Affordable Care Act
(Pub. L. 111–148) and the Health Care
and Education Reconciliation Act of
2010 (Pub. L. 111–152) (collectively, the
Patient Protection and Affordable Care
Act (PPACA)) were signed into law in
2010. The PPACA established
competitive private health insurance
markets, called Marketplaces or
Exchanges, which give millions of
Americans and small businesses access
to qualified health plans (QHPs),
including stand-alone dental plans
E:\FR\FM\11SEN1.SGM
11SEN1
Federal Register / Vol. 85, No. 177 / Friday, September 11, 2020 / Notices
(SADPs)—private health and dental
insurance plans that are certified as
meeting certain standards. The PPACA
added section 1150A of the Social
Security Act, which requires pharmacy
benefit managers (PBMs) to report
prescription benefit information to the
Department of Health and Human
Services (HHS). PBMs are third-party
administrators of prescription programs
for a variety of types of health plans,
including QHPs. The Centers for
Medicare and Medicaid Services (CMS)
files this information collection request
(ICR) in connection with the
prescription benefit information that
PBMs must provide to HHS under
section 1150A. The burden estimate for
this ICR reflects the time and effort for
PBMs to submit the information
regarding PBMs and prescription drugs.
Form Number: CMS–10725 (OMB
control number: 0938–NEW);
Frequency: Annually; Affected Public:
Private Sector (business or other forprofits), Number of Respondents: 40;
Number of Responses: 275. Total
Annual Hours: 1,400. For questions
regarding this collection contact Ken
Buerger at 410–786–1190.
4. Type of Information Collection
Request: New Collection; Title of
Information Collection: Value in Opioid
Use Disorder Treatment Demonstration;
Use: Value in Opioid Use Disorder
Treatment (Value in Treatment) is a 4year demonstration program authorized
under section 1866F of the Social
Security Act (Act), which was added by
section 6042 of the Substance UseDisorder Prevention that Promotes
Opioid Recovery and Treatment for
Patients and Communities Act
(SUPPORT Act). The purpose of Value
in Treatment, as stated in the statute, is
to ‘‘increase access of applicable
beneficiaries to opioid use disorder
treatment services, improve physical
and mental health outcomes for such
beneficiaries, and to the extent possible,
reduce Medicare program
expenditures.’’ As required by statute,
Value in Treatment will be
implemented no later than January 1,
2021.
Section 1866F(c)(1)(A)(ii) specifies
that individuals and entities must apply
for and be selected to participate in the
Value in Treatment demonstration
pursuant to an application and selection
process established by the Secretary.
Section 1866F(c)(2)(B)(iii) specifies that
in order to receive CMF and
performance-based incentive payments
under the Value in Treatment program,
each participant shall report data
necessary to: Monitor and evaluate the
Value in Treatment program; determine
if criteria are met; and determine the
VerDate Sep<11>2014
20:54 Sep 10, 2020
Jkt 250001
56229
performance-based incentive payment.
Form Number: CMS–10728 (OMB
control number: 0938-New); Frequency:
Yearly; Affected Public: Individuals and
Households; Number of Respondents:
12,096; Total Annual Responses:
12,096; Total Annual Hours: 1,285. (For
policy questions regarding this
collection contact Rebecca VanAmburg
at 410–786–0524.)
2020. The https://www.regulations.gov
electronic filing system will accept
comments until 11:59 p.m. Eastern Time
at the end of November 10, 2020.
Comments received by mail/hand
delivery/courier (for written/paper
submissions) will be considered timely
if they are postmarked or the delivery
service acceptance receipt is on or
before that date.
Dated: September 8, 2020.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office
of Strategic Operations and Regulatory
Affairs.
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
[FR Doc. 2020–20089 Filed 9–10–20; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2019–E–3015]
Determination of Regulatory Review
Period for Purposes of Patent
Extension; EVERSENSE CONTINUOUS
GLUCOSE MONITORING SYSTEM
Food and Drug Administration,
Health and Human Services (HHS).
ACTION: Notice.
AGENCY:
The Food and Drug
Administration (FDA or the Agency) has
determined the regulatory review period
for EVERSENSE CONTINUOUS
GLUCOSE MONITORING SYSTEM
(EVERSENSE CGM SYSTEM) and is
publishing this notice of that
determination as required by law. FDA
has made the determination because of
the submission of an application to the
Director of the U.S. Patent and
Trademark Office (USPTO), Department
of Commerce, for the extension of a
patent which claims that medical
device.
DATES: Anyone with knowledge that any
of the dates as published (see
SUPPLEMENTARY INFORMATION) are
incorrect may submit either electronic
or written comments and ask for a
redetermination by November 10, 2020.
Furthermore, any interested person may
petition FDA for a determination
regarding whether the applicant for
extension acted with due diligence
during the regulatory review period by
March 10, 2021. See ‘‘Petitions’’ in the
SUPPLEMENTARY INFORMATION section for
more information.
ADDRESSES: You may submit comments
as follows. Please note that late,
untimely filed comments will not be
considered. Electronic comments must
be submitted on or before November 10,
SUMMARY:
PO 00000
Frm 00018
Fmt 4703
Sfmt 4703
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand Delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2019–E–3015 for ‘‘Determination of
Regulatory Review Period for Purposes
of Patent Extension; EVERSENSE CGM
SYSTEM.’’ Received comments, those
filed in a timely manner (see
ADDRESSES), will be placed in the docket
and, except for those submitted as
‘‘Confidential Submissions,’’ publicly
viewable at https://www.regulations.gov
E:\FR\FM\11SEN1.SGM
11SEN1
Agencies
[Federal Register Volume 85, Number 177 (Friday, September 11, 2020)]
[Notices]
[Pages 56227-56229]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-20089]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[Document Identifier: CMS-359/CMS-360, CMS-10706, CMS-10725 and CMS
10728]
Agency Information Collection Activities: Submission for OMB
Review; Comment Request
AGENCY: Centers for Medicare & Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Medicare & Medicaid Services (CMS) is
announcing an opportunity for the public to comment on CMS' intention
to collect information from the public. Under the Paperwork Reduction
Act of 1995 (PRA), federal agencies are required to publish notice in
the Federal Register concerning each proposed collection of
information, including each proposed extension or reinstatement of an
existing collection of information, and to allow a second opportunity
for public comment on the notice. Interested persons are invited to
send comments regarding the burden estimate or any other aspect of this
collection of information, including the necessity and utility of the
proposed information collection for the proper performance of the
agency's functions, the accuracy of the estimated burden, ways to
enhance the quality, utility, and clarity of the information to be
collected, and the use of automated collection techniques or other
forms of information technology to minimize the information collection
burden.
[[Page 56228]]
DATES: Comments on the collection(s) of information must be received by
the OMB desk officer by October 13, 2020.
ADDRESSES: Written comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function.
To obtain copies of a supporting statement and any related forms
for the proposed collection(s) summarized in this notice, you may make
your request using one of following:
1. Access CMS' website address at website address at https://www.cms.gov/Regulations-and-Guidance/Legislation/PaperworkReductionActof1995/PRA-Listing.html.
2. Call the Reports Clearance Office at (410) 786-1326.
FOR FURTHER INFORMATION CONTACT: William Parham at (410) 786-4669.
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. The term ``collection of
information'' is defined in 44 U.S.C. 3502(3) and 5 CFR 1320.3(c) and
includes agency requests or requirements that members of the public
submit reports, keep records, or provide information to a third party.
Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A)) requires
federal agencies to publish a 30-day notice in the Federal Register
concerning each proposed collection of information, including each
proposed extension or reinstatement of an existing collection of
information, before submitting the collection to OMB for approval. To
comply with this requirement, CMS is publishing this notice that
summarizes the following proposed collection(s) of information for
public comment:
1. Type of Information Collection Request: Extension of a currently
approved information collection; Title of Information Collection:
Comprehensive Outpatient Rehabilitation Facility (CORF) Certification
and Survey Forms; Use: The form CMS-359 is an application for health
care providers that seek to participate in the Medicare program as a
Comprehensive Outpatient Rehabilitation Facility (CORF). The form
initiates the process for facilities to become certified as a CORF and
it provides the CMS Location and State Survey Agency (SA) staff
identifying information regarding the applicant that is stored in the
Automated Survey Processing Environment (ASPEN) system.
The form CMS-360 is a survey tool used by the SAs to record
information in order to determine a provider's compliance with the CORF
Conditions of Participation (COPs) and to report this information to
the Federal government. The form includes basic information on the COP
requirements, check boxes to indicate the level of compliance, and a
section for recording notes. CMS has the responsibility and authority
for certification decisions which are based on provider compliance with
the COPs and this form supports this process. Form Number: CMS-359/360
(OMB control number: 0938-0267); Frequency: Occasionally; Affected
Public: Private Sector (Business or other for-profits); Number of
Respondents: 49 Number of Responses: 8; Total Annual Hours: 74. (For
questions regarding this collection contact Caroline Gallaher (410)786-
8705.)
2. Type of Information Collection Request: New collection (Request
for a new OMB control number); Title of Information Collection: Generic
Clearance for the Center for Clinical Standards and Quality IT Product
and Support Teams; Use: The Health Information Technology for Economic
and Clinical Health (HITECH) Act is part of the American Reinvestment
and Recovery Act (ARRA) of 2009. As noted in the HITECH Act, CMS is
responsible for defining ``meaningful use'' of certified electronic
health record (EHR) technology and developing incentive payment
programs for Medicare and Medicaid providers. CMS is continually
implementing and updating information systems as legislation and
requirements change. To support this initiative, CCSQ IT Product and
Support Teams (CIPST) must have the capacity for engagement with users
in an ongoing variety of research, discovery, and validation activities
to create and refine systems that do not place an undue burden on users
and instead are efficient, usable, and desirable.
The Center for Clinical Standards and Quality (CCSQ) is responsible
for administering appropriate information systems so that the public
can submit healthcare-related information. While beneficiaries
ultimately benefit, the primary users of (CIPST) are healthcare
facility employees and contractors. They are responsible for the
collection and submission of appropriate beneficiary data to CMS to
receive merit-based compensation.
The generic clearance will allow a rapid response to inform CMS
initiatives using a mixture of qualitative and quantitative consumer
research strategies (including formative research studies and
methodological tests) to improve information systems that serve CMS
audiences. CMS implements human-centered methods and activities for the
improvement of policies, services, and products. As information systems
and technologies are developed or improved upon, they can be tested and
evaluated for end-user feedback regarding utility, usability, and
desirability. The overall goal is to apply a human-centered engagement
model to maximize the extent to which CMS CIPST product teams can
gather ongoing feedback from consumers. Feedback helps engineers and
designers arrive at better solutions, therefore minimizing the burden
on consumers and meeting their needs and goals.
The activities under this clearance involve voluntary engagement
with target CIPST users to receive design and research feedback.
Voluntary end-users from samples of self-selected customers, as well as
convenience samples, with respondents selected either to cover a broad
range of customers or to include specific characteristics related to
certain products or services. All collection of information under this
clearance is for use in both quantitative and qualitative groups
collecting data related to human-computer interactions with information
system development. We will use the findings to create the highest
possible public benefit. Form Number: CMS-10706 (OMB control number:
0938-NEW); Frequency: Occasionally; Affected Public: Individuals and
Private Sector (Business or other for-profit and Not-for-profit
institutions); Number of Respondents: 11,476; Total Annual Responses:
11,476; Total Annual Hours: 4,957. (For policy questions regarding this
collection contact Stephanie Ray at 410-786-0971).
3. Type of Information Collection Request: New information
collection; Title of Information Collection: Pharmacy Benefit Manager
Transparency; Use: The Patient Protection and Affordable Care Act (Pub.
L. 111-148) and the Health Care and Education Reconciliation Act of
2010 (Pub. L. 111-152) (collectively, the Patient Protection and
Affordable Care Act (PPACA)) were signed into law in 2010. The PPACA
established competitive private health insurance markets, called
Marketplaces or Exchanges, which give millions of Americans and small
businesses access to qualified health plans (QHPs), including stand-
alone dental plans
[[Page 56229]]
(SADPs)--private health and dental insurance plans that are certified
as meeting certain standards. The PPACA added section 1150A of the
Social Security Act, which requires pharmacy benefit managers (PBMs) to
report prescription benefit information to the Department of Health and
Human Services (HHS). PBMs are third-party administrators of
prescription programs for a variety of types of health plans, including
QHPs. The Centers for Medicare and Medicaid Services (CMS) files this
information collection request (ICR) in connection with the
prescription benefit information that PBMs must provide to HHS under
section 1150A. The burden estimate for this ICR reflects the time and
effort for PBMs to submit the information regarding PBMs and
prescription drugs. Form Number: CMS-10725 (OMB control number: 0938-
NEW); Frequency: Annually; Affected Public: Private Sector (business or
other for-profits), Number of Respondents: 40; Number of Responses:
275. Total Annual Hours: 1,400. For questions regarding this collection
contact Ken Buerger at 410-786-1190.
4. Type of Information Collection Request: New Collection; Title of
Information Collection: Value in Opioid Use Disorder Treatment
Demonstration; Use: Value in Opioid Use Disorder Treatment (Value in
Treatment) is a 4-year demonstration program authorized under section
1866F of the Social Security Act (Act), which was added by section 6042
of the Substance Use-Disorder Prevention that Promotes Opioid Recovery
and Treatment for Patients and Communities Act (SUPPORT Act). The
purpose of Value in Treatment, as stated in the statute, is to
``increase access of applicable beneficiaries to opioid use disorder
treatment services, improve physical and mental health outcomes for
such beneficiaries, and to the extent possible, reduce Medicare program
expenditures.'' As required by statute, Value in Treatment will be
implemented no later than January 1, 2021.
Section 1866F(c)(1)(A)(ii) specifies that individuals and entities
must apply for and be selected to participate in the Value in Treatment
demonstration pursuant to an application and selection process
established by the Secretary. Section 1866F(c)(2)(B)(iii) specifies
that in order to receive CMF and performance-based incentive payments
under the Value in Treatment program, each participant shall report
data necessary to: Monitor and evaluate the Value in Treatment program;
determine if criteria are met; and determine the performance-based
incentive payment. Form Number: CMS-10728 (OMB control number: 0938-
New); Frequency: Yearly; Affected Public: Individuals and Households;
Number of Respondents: 12,096; Total Annual Responses: 12,096; Total
Annual Hours: 1,285. (For policy questions regarding this collection
contact Rebecca VanAmburg at 410-786-0524.)
Dated: September 8, 2020.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office of Strategic Operations and
Regulatory Affairs.
[FR Doc. 2020-20089 Filed 9-10-20; 8:45 am]
BILLING CODE 4120-01-P